Cite
HARVARD Citation
Wang, P. et al. (n.d.). Efficacy and safety of short‐term administration of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a phase II, multicentre randomized controlled dose‐finding study. Journal of clinical pharmacy and therapeutics. pp. 388-393. [Online].